The initiation of an immune response is critically dependent on the activation of dendritic cells (DCs). This process is triggered by surface receptors specific for inflammatory cytokines or for conserved patterns characteristic of infectious agents. Here we show that human DCs are activated by influenza virus infection and by double-stranded (ds)RNA. This activation results not only in increased antigen presentation and T cell stimulatory capacity, but also in resistance to the cytopathic effect of the virus, mediated by the production of type I interferon, and upregulation of MxA. Because dsRNA stimulates both maturation and resistance, DCs can serve as altruistic antigen-presenting cells capable of sustaining viral antigen production while acquiring the capacity to trigger naive T cells and drive polarized T helper cell type 1 responses.
Skip Nav Destination
Article navigation
1 March 1999
Article|
March 01 1999
Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA
Marina Cella,
Marina Cella
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Search for other works by this author on:
Mariolina Salio,
Mariolina Salio
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Search for other works by this author on:
Yoichi Sakakibara,
Yoichi Sakakibara
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Search for other works by this author on:
Hanno Langen,
Hanno Langen
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Search for other works by this author on:
Ilkka Julkunen,
Ilkka Julkunen
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Search for other works by this author on:
Antonio Lanzavecchia
Antonio Lanzavecchia
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Search for other works by this author on:
Marina Cella
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Mariolina Salio
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Yoichi Sakakibara
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Hanno Langen
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Ilkka Julkunen
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Antonio Lanzavecchia
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; ‡Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the §National Public Health Institute, FIN-00300, Helsinki, Finland
Address correspondence to Marina Cella or Antonio Lanzavecchia, Basel Institute for Immunology, Grenzacherstrasse 487, CH 4005 Basel, Switzerland. Phone: 41-61-6051326; Fax: 41-61-6051222; E-mail: [email protected] or [email protected]
M. Salio holds an EC fellowship (EUNIDI). The Basel Institute for Immunology was founded and is supported by Hoffmann-La Roche, Basel, Switzerland.
Received:
November 10 1998
Revision Received:
January 07 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1999
J Exp Med (1999) 189 (5): 821–829.
Article history
Received:
November 10 1998
Revision Received:
January 07 1999
Citation
Marina Cella, Mariolina Salio, Yoichi Sakakibara, Hanno Langen, Ilkka Julkunen, Antonio Lanzavecchia; Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA . J Exp Med 1 March 1999; 189 (5): 821–829. doi: https://doi.org/10.1084/jem.189.5.821
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement